Patents by Inventor John E. Tellew

John E. Tellew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors
    Patent number: 9181238
    Abstract: The invention provides a novel class of compounds of Formula (I) (wherein A, Y, R2, R3, R4 and R5 are defined in the summary of the invention), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: November 10, 2015
    Assignee: NOVARTIS AG
    Inventors: Shifeng Pan, John E. Tellew, Yongqin Wan, Yongping Xie, Xing Wang, Xia Wang, Shenlin Huang, Zuosheng Liu, Qiong Zhang
  • COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
    Publication number: 20130143899
    Abstract: The invention provides a novel class of compounds of Formula (I) (wherein A, Y, R2, R3, R4 and R5 are defined in the summary of the invention), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
    Type: Application
    Filed: February 4, 2011
    Publication date: June 6, 2013
    Inventors: Shifeng Pan, John E. Tellew, Yongqin Wan, Yongping Xie, Xing Wang, Xia Wang, Shenlin Huang, Zuosheng Liu, Qiong Zhang
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Patent number: 6852745
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: February 8, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Natesan Murugesan, John E. Tellew, John E. Macor, Zhengxiang Gu
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Patent number: 6835741
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: December 28, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Natesan Murugesan, John E. Tellew, John E. Macor, Zhengxiang Gu
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Publication number: 20040127515
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: September 26, 2003
    Publication date: July 1, 2004
    Inventors: Natesan Murugesan, John E. Tellew, John E. Macor, Zhengxiang Gu
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Publication number: 20040106833
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: September 26, 2003
    Publication date: June 3, 2004
    Inventors: Natesan Murug San, John E. Tellew, John E. Macor, Zhengxiang Gu
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Patent number: 6638937
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: December 14, 2000
    Date of Patent: October 28, 2003
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Natesan Murugesan, John E. Tellew, John E. Macor, Zhengxiang Gu
  • Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
    Publication number: 20020143024
    Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 14, 2000
    Publication date: October 3, 2002
    Inventors: Natesan Murugesan, John E. Tellew, Jhon E. Macor, Zhengxiang Gu